Advanced search×

Phylogeny of early Australopithecus: new fossil evidence from the Woranso-Mille (central Afar, Ethiopia).

Philos Trans R Soc Lond B Biol Sci 365(1556):3323-31 (2010) PMID 20855306

The earliest evidence of Australopithecus goes back to ca 4.2 Ma with the first recorded appearance of Australopithecus 'anamensis' at Kanapoi, Kenya. Australopithecus afarensis is well documented between 3.6 and 3.0 Ma mainly from deposits at Laetoli (Tanzania) and Hadar (Ethiopia). The phylogenetic relationship of these two 'species' is hypothesized as ancestor-descendant. However, the lack of fossil evidence from the time between 3.6 and 3.9 Ma has been one of its weakest points. Recent fieldwork in the Woranso-Mille study area in the Afar region of Ethiopia has yielded fossil hominids dated between 3.6 and 3.8 Ma. These new fossils play a significant role in testing the proposed relationship between Au. anamensis and Au. afarensis. The Woranso-Mille hominids (3.6-3.8 Ma) show a mosaic of primitive, predominantly Au. anamensis-like, and some derived (Au. afarensis-like) dentognathic features. Furthermore, they show that, as currently known, there are no discrete and functionally significant anatomical differences between Au. anamensis and Au. afarensis. Based on the currently available evidence, it appears that there is no compelling evidence to falsify the hypothesis of 'chronospecies pair' or ancestor-descendant relationship between Au. anamensis and Au. afarensis. Most importantly, however, the temporally and morphologically intermediate Woranso-Mille hominids indicate that the species names Au. afarensis and Au. anamensis do not refer to two real species, but rather to earlier and later representatives of a single phyletically evolving lineage. However, if retaining these two names is necessary for communication purposes, the Woranso-Mille hominids are best referred to as Au. anamensis based on new dentognathic evidence.

DOI: 10.1098/rstb.2010.0064
Version: za2963e q8za0 q8zb5 q8zc1 q8zdb q8zed q8zf1 q8zg6

Similar articles you may find interesting…

  1. [Allergen immunotherapy for allergic rhinitis.]

    Rhinology 51(2):99-110 (2013) PMID 23671890

    Allergic rhinitis, a risk factor for bronchial asthma, is a global health problem that impairs patients` physical and social activity and consequently their quality of life. Specific Immunotherapy (SIT) involves the administration, subcutaneously or sublin- gually, of increasing dose...
  2. The lupus anticoagulant: results from 2257 patients attending a high-risk pregnancy clinic.

    Blood (2013) PMID 23649468

    We measure LAC using a 4-assay panel that expands upon the 2 assays recommended by the International Society for Thrombosis and Haemostatis (ISTH) guidelines. Of 2,257 patients tested for LAC over a 6-year period, 62 were repeatedly positive (2.7%). Only 5 (0.2%) patients had both a history of early...
  3. The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?

    Expert Opin Drug Discov (2013) PMID 23642051

    Pigment epithelium-derived factor (PEDF) was discovered as a neurotrophic factor secreted by retinal pigment epithelial cells. A decade later, it re-emerged as a powerful angiogenesis inhibitor guarding ocular function. Since then, significant advances were made identifying PEDF's mechanisms, target...